These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril]. Rapezzi C; Ciliberti P; Graziosi M; Riva L Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516 [TBL] [Abstract][Full Text] [Related]
10. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Ceconi C; Fox KM; Remme WJ; Simoons ML; Bertrand M; Parrinello G; Kluft C; Blann A; Cokkinos D; Ferrari R; ; Cardiovasc Res; 2007 Jan; 73(1):237-46. PubMed ID: 17140552 [TBL] [Abstract][Full Text] [Related]
11. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension. Yamada Y; Tsuboi K; Hattori T; Murase T; Ohtake M; Furukawa M; Ueyama J; Nishiyama A; Murohara T; Nagata K Hypertens Res; 2011 Jul; 34(7):809-16. PubMed ID: 21471973 [TBL] [Abstract][Full Text] [Related]
12. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs. Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525 [TBL] [Abstract][Full Text] [Related]
14. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017 [TBL] [Abstract][Full Text] [Related]
15. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Yoshiji H; Kuriyama S; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H Clin Cancer Res; 2001 Apr; 7(4):1073-8. PubMed ID: 11309359 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Toblli JE; Cao G; DeRosa G; Di Gennaro F; Forcada P Am J Hypertens; 2004 Feb; 17(2):172-80. PubMed ID: 14751661 [TBL] [Abstract][Full Text] [Related]
17. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479 [TBL] [Abstract][Full Text] [Related]
18. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure. Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215 [TBL] [Abstract][Full Text] [Related]
19. Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats. Kobayashi N; Higashi T; Hara K; Shirataki H; Matsuoka H Cardiovasc Res; 1999 Dec; 44(3):518-26. PubMed ID: 10690283 [TBL] [Abstract][Full Text] [Related]
20. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]